FMP
Liquidia Corporation
LQDA
NASDAQ
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
12.37 USD
-0.18 (-1.46%)
About
ceo
Dr. Roger A. Jeffs Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.liquidia.com
exchange
NASDAQ
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
CIK
0001819576
ISIN
US53635D2027
CUSIP
53635D202
Address
419 Davis Drive
Phone
919 328 4400
Country
US
Employee
145
IPO Date
Jul 26, 2018
Summary
CIK
0001819576
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
53635D202
ISIN
US53635D2027
Country
US
Price
12.37
Beta
0.19
Volume Avg.
840.27k
Market Cap
940.46M
Shares
-
52-Week
5.71-16.99
DCF
-10.64
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-10.22
P/B
-
Website
https://www.liquidia.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest LQDA News
It looks like there's no news available.
